unknown
Stage
1
Investors
About
Crossbow Therapeutics develops antibody-based cancer therapeutics aimed at expanding the range of targetable cancer antigens to create more potent and precise oncology treatments.
Explore Crossbow Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.